ImportRefusal LogoImportRefusal

De Los Angeles Investment Sas

⚠️ High Risk

FEI: 3014199523 • Bucaramanga, Santander • COLOMBIA

FEI

FEI Number

3014199523

📍

Location

Bucaramanga, Santander

🇨🇴

Country

COLOMBIA
🏢

Address

Torre 1, Calle 41 No 38-125 Apatamento 803, Bucaramanga, Santander, Colombia

High Risk

FDA Import Risk Assessment

61.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

1
Total Refusals
1
Unique Violations
5/28/2025
Latest Refusal
5/28/2025
Earliest Refusal

Score Breakdown

Violation Severity
100.0×40%
Refusal Volume
11.2×30%
Recency
87.3×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2411×

PESTICIDE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a pesticide chemical residue, which causes the article to be adulterated within the meaning of section 402(a)(2)(B) of the FD&C Act. Bears or contains:

Refusal History

DateProductViolationsDivision
5/28/2025
20GFC05LIME (CITRUS)
241PESTICIDE
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is De Los Angeles Investment Sas's FDA import refusal history?

De Los Angeles Investment Sas (FEI: 3014199523) has 1 FDA import refusal record(s) in our database, spanning from 5/28/2025 to 5/28/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. De Los Angeles Investment Sas's FEI number is 3014199523.

What types of violations has De Los Angeles Investment Sas received?

De Los Angeles Investment Sas has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about De Los Angeles Investment Sas come from?

All FDA import refusal data for De Los Angeles Investment Sas is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.